Anest. intenziv. Med. 2013;24(4):226-229

Quo vadis sepse?Editorial

Miroslav Průcha
Oddělení klinické biochemie, hematologie a imunologie, Nemocnice Na Homolce, Praha

Published: August 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Průcha M. Quo vadis sepse? Anest. intenziv. Med. 2013;24(4):226-229.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Schwarz, D., Adamus, M., Černý, V., Dušek, L. et al. EPOSS & SEPSIS Q: návrh a popis řešení projektů pro sledování léčby, morbidity a mortality pacientů s těžkou sepsí v České republice. Anest. intenziv. Med., 2013, 24, 4, s. 00-00.
    2. Karvunidis, T., Lysák, D., Chvojka, J., Ledvinová, L., Raděj, J.,Novák, I., Matějovič, M. Imunitní homeostáza (deregulace) v sepsi a septickém šoku. Anest. intenziv. Med., 2013, 24, 4, s. 00-00.
    3. Shay, T., Jojic, V., Zuk, O. et al. ImmGen Consortium. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc. Natl. Acad Sci USA,2013, 110, p. 2946-2951. Go to original source... Go to PubMed...
    4. Ernst, W., Zimara, N., Hanses, F. et al. Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis. Infect. Immun., 2013, 81, p. 1520-1531. Go to original source... Go to PubMed...
    5. Xiao, W., Mindrinos, M. N., Seok, J. et al. A genomic storm in crtitically injured humans. J. Experimental. Med., 2011, 208, p. 2581-2590. Go to original source... Go to PubMed...
    6. Otto, G. P., Sossdorf, M., Claus, R. A. et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Crit. Care, 2011,15, p. R183. Go to original source... Go to PubMed...
    7. Boomer, J. S. et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA, 2011, 306, p. 2594-2605. Go to original source... Go to PubMed...
    8. Osuchowski, M. F., Welch, K., Yang, H., Siddiqui, J.,Remick, D. G. Chronic Sepsis Mortality Characterized by an Individualized Inflammatory Response. J. Immunol., 2007, 179, p. 623-630. Go to original source... Go to PubMed...
    9. Hotchkiss, R. S., Coopersmith, C. M., McDun, J. E.,Ferguson, T. A. Tilting toward immunosuppression. Nature Medicine, 2009, 15, p. 496-497. Go to original source... Go to PubMed...
    10. Boomer, J. S., Shuherk-Shaffer, J., Hotchkiss, R. S.,Green, J. M. A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis. Crit. Care, 2012, 16, p. R112. Go to original source... Go to PubMed...
    11. Sutherland, A., Thomas, M., Brandon, R. A. et al. Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis. Crit. Care, 2011, 15, p. R149. Go to original source... Go to PubMed...
    12. Johnson, S. B., Lissauer, M., Bochicchio, G. V. et al. Gene Expression Profiles Differentiate Between Sterile SIRS and Early Sepsis. Ann. Surg., 2007, 245, p. 611-621. Go to original source... Go to PubMed...
    13. Lissauer, M. E., Johnson, S. B., Siuzdak, G. et al. Coagulation and complement protein differences between septic and uninfected systemic inflammatory response syndrome patients.J. Trauma, 2007, 62, p. 1082-1094. Go to original source... Go to PubMed...
    14. Hawiger, J., Musser, J. M. How to approach genome wars in sepsis? Crit. Care, 2011, 15, p. 1007. doi: 10.1186/cc10482 Go to original source... Go to PubMed...
    15. Kaczewski, K. J. The future of genomic medicine is here. Genome Biology, 2013, 14, p. 304. Go to original source... Go to PubMed...
    16. Lacy, P. Metabolomics of sepsis-induced acute lung injury: a new approach for biomarkers. Am. J. Physiol. Lung Cell Mol. Physiol., 2011, 300, p. L1-3. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.